Heart News and Research

RSS

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

Sugary drinks could raise risk of early deaths finds study

A new study has revealed that sugary drinks or drinks that are artificially sweetened (SSB or sugar sweetened beverages) are bad for heart health. Drinking two or more of these drinks per day can lead to a 31 percent raised risk of early death due to heart disease explain the researchers.

20 Mar 2019

New study identifies CD40 molecule as key entry point for dangerous bacteria

A new study identifies a single molecule as a key entry point used by two types of dangerous bacteria to break through cellular barriers and cause disease.

20 Mar 2019

Are eggs good or bad for you?

To have eggs or not is the question! There have been endless debates on whether having eggs regularly could raise the risk of heart disease.

19 Mar 2019

Apple watch could detect irregular heart beat says study

A new study has shown that the latest Apple Watch is capable of detecting irregular heartbeats in the user. This is a significant step towards wearable healthcare devices says Apple.

19 Mar 2019

Cholesterol lowering drug can also help treat cancer-associated cachexia

Brazilian researchers have discovered that a drug regularly prescribed to control cholesterol can also be used to treat cachexia, or wasting syndrome, a condition characterized by rapid weight loss and muscle atrophy associated with extreme physical weakness.

19 Mar 2019

Breastfeeding may offer long-term heart health benefits for women

Mothers who breastfeed their babies have a lower risk of developing or dying from heart disease than those who don't breastfeed, finds new research from the University of Sydney, Australia.

19 Mar 2019

New study examines smarter automatic defibrillator

Thousands of patients with congestive heart failure benefit from automatic implantable cardiac defibrillators that deliver shocks to the heart to correct abnormal heart rhythms. These defibrillators improve survival in patients who are at risk for sudden cardiac death.

19 Mar 2019

Framingham cardiovascular risk prediction model from the 1990s still gives the best results

The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA between 1968 and 1975. It is named after the town of the same name in Massachusetts, where a systematic evaluation of heart health had previously been conducted in the late 1940s.

19 Mar 2019

Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events

Taking a high dose of icosapent ethyl--a pure and stable prescription form of the omega-3 fatty acid known as EPA--significantly reduces the occurrence of first, subsequent and total ischemic events, including heart attacks, strokes and related deaths, among people at high cardiovascular risk despite already being on statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

Lack of health insurance may increase Aging immigrants’ risk for cardiovascular disease

Aging immigrants' risk for cardiovascular disease may be heightened by their lack of health insurance, particularly among those who recently arrived in the United States, finds a study led by researchers at NYU Rory Meyers College of Nursing.

19 Mar 2019

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning medication clopidogrel versus the newer, more potent drug ticagrelor, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Study: Radial or femoral approaches for PCI are equal in terms of survival in heart attack patients

Doctors can use either an artery in the arm (the radial approach) or in the groin (the femoral approach) to safely perform percutaneous coronary intervention (PCI) on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session. The research, which was stopped early, suggests the radial and femoral approach are equivalent in terms of the risk of death at 30 days.

19 Mar 2019

Study sheds light on the optimal timing of coronary angiography in NSTEMI patients

In patients resuscitated after cardiac arrest who do not show evidence of the type of heart attack known as ST-segment elevation myocardial infarction (STEMI), receiving immediate coronary angiography did not improve survival at 90 days compared to waiting a few days before undergoing the procedure, based on findings presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Radial and femoral approach for PCI achieve similar results in terms of survival

Doctors can use either an artery in the arm or in the groin to safely perform percutaneous coronary intervention on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

Less invasive valve replacement can be safe and effective alternative for healthier patients

A new study by a team of cardiologists at Beth Israel Deaconess Medical Center led by senior and corresponding author Jeffrey Popma, MD, suggests that a minimally invasive procedure currently reserved for patients too frail to undergo surgery may in fact be a safe and effective alternative for healthier patients.

19 Mar 2019

Study indicates the benefits of stopping aspirin in heart attack patients

Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death from any cause, heart attack or stroke after a year compared with those receiving standard therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

Two-drug combinations containing calcium channel blocker significantly lowers BP

In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel blocker, amlodipine, were able to drive down blood pressure levels more than a third two-drug combination that did not include amlodipine, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

19 Mar 2019

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or "bad" cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session.

19 Mar 2019

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

The nation's first African-American Neuroscience Research Initiative, aimed at ensuring that genomic research and neuroscience studies are representative of individuals across all populations including African ancestry, launched today.

19 Mar 2019

Heart News and Research

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Sugary drinks could raise risk of early deaths finds study

New study identifies CD40 molecule as key entry point for dangerous bacteria

Are eggs good or bad for you?

Apple watch could detect irregular heart beat says study

Cholesterol lowering drug can also help treat cancer-associated cachexia

Breastfeeding may offer long-term heart health benefits for women

New study examines smarter automatic defibrillator

Framingham cardiovascular risk prediction model from the 1990s still gives the best results

Research: Pure omega-3 prescription drug significantly reduces the occurrence of ischemic events

Lack of health insurance may increase Aging immigrants’ risk for cardiovascular disease

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study: Radial or femoral approaches for PCI are equal in terms of survival in heart attack patients

Study sheds light on the optimal timing of coronary angiography in NSTEMI patients

Radial and femoral approach for PCI achieve similar results in terms of survival

Less invasive valve replacement can be safe and effective alternative for healthier patients

Study indicates the benefits of stopping aspirin in heart attack patients

Two-drug combinations containing calcium channel blocker significantly lowers BP

A new option for reducing LDL cholesterol in patients at high risk for heart attack, stroke

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News